Header Logo

Neilayan Sen

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiation Oncology
3
2019
14
0.450
 Why?
Pancreatic Neoplasms
1
2014
86
0.410
 Why?
Employment
2
2018
39
0.280
 Why?
Chemoradiotherapy
2
2019
55
0.260
 Why?
Sarcoma
2
2019
71
0.260
 Why?
Internship and Residency
2
2019
199
0.230
 Why?
Carcinoma, Non-Small-Cell Lung
2
2017
232
0.210
 Why?
Lung Neoplasms
2
2017
536
0.180
 Why?
Human papillomavirus 16
1
2019
6
0.160
 Why?
Oropharyngeal Neoplasms
1
2019
19
0.150
 Why?
Biopsy, Fine-Needle
1
2019
61
0.150
 Why?
Career Choice
1
2018
24
0.150
 Why?
Tongue Neoplasms
1
2018
18
0.150
 Why?
Neoadjuvant Therapy
2
2019
53
0.150
 Why?
Carcinoma, Squamous Cell
1
2019
162
0.140
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
198
0.140
 Why?
Radiosurgery
1
2017
32
0.130
 Why?
Prognosis
2
2019
674
0.130
 Why?
Brachytherapy
1
2016
44
0.120
 Why?
Radiotherapy, Adjuvant
1
2014
45
0.110
 Why?
Humans
10
2019
24703
0.100
 Why?
United States
4
2019
1873
0.100
 Why?
Retrospective Studies
4
2019
3156
0.080
 Why?
Treatment Outcome
4
2019
3208
0.080
 Why?
Male
6
2019
13669
0.070
 Why?
Female
6
2019
14048
0.070
 Why?
Chi-Square Distribution
2
2018
125
0.070
 Why?
Disease-Free Survival
2
2018
145
0.070
 Why?
Databases, Factual
2
2019
315
0.060
 Why?
Adult
4
2019
7255
0.060
 Why?
Neoplasm Staging
2
2018
332
0.060
 Why?
Cohort Studies
2
2019
1748
0.050
 Why?
Aged
3
2019
8382
0.040
 Why?
Genetic Heterogeneity
1
2019
8
0.040
 Why?
Mesna
1
2019
3
0.040
 Why?
Ifosfamide
1
2019
6
0.040
 Why?
Population Density
1
2018
3
0.040
 Why?
Job Application
1
2018
5
0.040
 Why?
Clinical Decision-Making
1
2019
41
0.040
 Why?
Cities
1
2018
15
0.040
 Why?
Doxorubicin
1
2019
32
0.040
 Why?
Reference Values
1
2019
174
0.040
 Why?
Organ Sparing Treatments
1
2019
11
0.040
 Why?
Leg
1
2019
46
0.040
 Why?
Schools, Medical
1
2018
26
0.040
 Why?
Consumer Behavior
1
2018
23
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2018
29
0.040
 Why?
Combined Modality Therapy
1
2019
278
0.040
 Why?
Arm
1
2019
83
0.040
 Why?
Neoplasm Invasiveness
1
2018
85
0.040
 Why?
Analysis of Variance
1
2018
243
0.040
 Why?
Survival Rate
1
2018
285
0.030
 Why?
Professional Practice Location
1
2017
2
0.030
 Why?
Academies and Institutes
1
2017
11
0.030
 Why?
Censuses
1
2017
9
0.030
 Why?
Radiotherapy Dosage
1
2017
95
0.030
 Why?
Patient Safety
1
2017
31
0.030
 Why?
Kaplan-Meier Estimate
1
2017
138
0.030
 Why?
Risk Assessment
1
2019
532
0.030
 Why?
Societies, Medical
1
2017
118
0.030
 Why?
Middle Aged
2
2019
8294
0.030
 Why?
Registries
1
2017
176
0.030
 Why?
Age Factors
1
2018
728
0.030
 Why?
Chemoradiotherapy, Adjuvant
1
2015
14
0.030
 Why?
Survival Analysis
1
2015
231
0.030
 Why?
Surveys and Questionnaires
1
2018
1042
0.030
 Why?
Adolescent
1
2018
1992
0.030
 Why?
Prospective Studies
1
2017
1612
0.020
 Why?
Young Adult
1
2018
1847
0.020
 Why?
Follow-Up Studies
1
2017
1671
0.020
 Why?
Aged, 80 and over
1
2017
4509
0.020
 Why?
Sen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_